NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding NextCure, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 44 | 43 | −1 |
| Shares | 13.3M | 13.3M | +53.6K (+0.4%) |
| Value | $19.6M | $24.0M | +$4.34M (+22.1%) |
New holders (5)
Institutions that held NextCure, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acuitas Investments, LLC | 286,834 | $516.3K | 0.30% |
| Cardiff Park Advisors, LLC | 262,000 | $471.6K | 0.06% |
| Assenagon Asset Management S.A. | 43,917 | $79.1K | 0.00% |
| Ieq Capital, LLC | 37,342 | $67.2K | 0.00% |
| Rhumbline Advisers | 703 | $1.26K | 0.00% |
Sold out (6)
Institutions that held NextCure, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Goldman Sachs Group Inc | 93,478 | $138.3K |
| Norges Bank | 51,900 | $76.8K |
| Marquette Asset Management, LLC | 51,425 | $76.1K |
| Minerva Advisors LLC | 31,713 | $46.9K |
| Group One Trading, L.P. | 846 | $1.25K |
| Bank of America Corp | 3 | $3 |